Cargando…

Locoregional recurrence patterns in women with breast cancer who have not undergone post-mastectomy radiotherapy

BACKGROUND: To analyze the patterns of locoregional recurrence in breast cancer patients after mastectomy. METHODS: The retrospective study included 7073 women with breast cancer without post-mastectomy radiotherapy: 4604 (65.1%) had pT1–2 N0 disease (low risk); 2042 (28.9%), pT1–2 N1 (intermediate...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhao, Xuran, Tang, Yu, Wang, Shulian, Yang, Yong, Fang, Hui, Wang, Jianyang, Jing, Hao, Zhang, Jianghu, Sun, Guangyi, Chen, Siye, Jin, Jing, Song, Yongwen, Liu, Yueping, Chen, Bo, Qi, Shunan, Li, Ning, Tang, Yuan, Lu, Ningning, Ren, Hua, Li, Yexiong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2020
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7487762/ https://www.ncbi.nlm.nih.gov/pubmed/32887640 http://dx.doi.org/10.1186/s13014-020-01637-w

Ejemplares similares

Risk stratification for prediction of locoregional recurrence in patients with pathologic T1–2N0 breast cancer after mastectomy
por: Wang, Jianyang, et al.
Publicado: (2020)

Effectiveness of the AJCC 8th edition staging system for selecting patients with T1–2N1 breast cancer for post-mastectomy radiotherapy: a joint analysis of 1986 patients from two institutions
por: Wang, Shulian, et al.
Publicado: (2020)

Comparison of outcome and toxicity of postoperative intensity‐modulated radiation therapy with two‐dimensional radiotherapy in patients with soft tissue sarcoma of extremities and trunk
por: Wang, Jianyang, et al.
Publicado: (2019)

Assessment and validation of the internal gross tumour volume of gastroesophageal junction cancer during simultaneous integrated boost radiotherapy
por: Shi, Jinming, et al.
Publicado: (2022)

Development and Validation of an MRI-Based Nomogram Model for Predicting Disease-Free Survival in Locally Advanced Rectal Cancer Treated With Neoadjuvant Radiotherapy
por: Chen, Silin, et al.
Publicado: (2021)

Long-term outcomes of moderately hypofractionated radiotherapy (67.5 Gy in 25 fractions) for prostate cancer confined to the pelvis: a single center retrospective analysis
por: Yao, Lihong, et al.
Publicado: (2020)

A Phase II prospective nonrandomized trial of magnetic resonance imaging-guided hematopoietic bone marrow-sparing radiotherapy for gastric cancer patients with concurrent chemotherapy
por: Wang, Jianyang, et al.
Publicado: (2016)

Postoperative intensity-modulated radiation therapy provides favorable local control and low toxicities in patients with soft tissue sarcomas in the extremities and trunk wall
por: Wang, Jianyang, et al.
Publicado: (2015)

Preoperative versus postoperative chemo-radiotherapy for locally advanced gastric cancer: a multicenter propensity score-matched analysis
por: Li, Ning, et al.
Publicado: (2022)

Prospective evaluation of microscopic extension using whole-mount preparation in patients with hepatocellular carcinoma: Definition of clinical target volume for radiotherapy
por: Wang, Weihu, et al.
Publicado: (2010)

Adjuvant Chemoradiotherapy Versus Adjuvant Chemotherapy for Stage III Gastric or Gastroesophageal Junction Cancer After D2/R0 Resection
por: Shi, Jinming, et al.
Publicado: (2022)

Inter‐ and intrafractional setup errors and baseline shifts of fiducial markers in patients with liver tumors receiving free‐breathing postoperative radiation analyzed by cone‐beam computed tomography
por: Zhang, Tao, et al.
Publicado: (2014)

Radiomics Analysis of Fat-Saturated T2-Weighted MRI Sequences for the Prediction of Prognosis in Soft Tissue Sarcoma of the Extremities and Trunk Treated With Neoadjuvant Radiotherapy
por: Chen, Silin, et al.
Publicado: (2021)

A prospective phase I study of hypo-fractionated neoadjuvant radiotherapy for locally advanced gastric cancer
por: Li, Ning, et al.
Publicado: (2018)

Down-staging depth score could be a survival predictor for locally advanced gastric cancer patients after preoperative chemoradiotherapy
por: Li, Ning, et al.
Publicado: (2021)

Total neoadjuvant therapy for locally advanced gastric cancer and esophagogastric junction adenocarcinoma: study protocol for a prospective, multicenter, single-arm, phase II clinical trial
por: Shi, Jinming, et al.
Publicado: (2022)

CNN-Based Quality Assurance for Automatic Segmentation of Breast Cancer in Radiotherapy
por: Chen, Xinyuan, et al.
Publicado: (2020)

The Influence of External Breast Prostheses on the Body Postures of Women Who Have Undergone Mastectomies
por: Koralewska, Anna, et al.
Publicado: (2023)

Development and external validation of a nomogram to predict four or more positive nodes in breast cancer patients with one to three positive sentinel lymph nodes
por: Yang, Zhuanbo, et al.
Publicado: (2020)

Circulating serum microRNA-345 correlates with unfavorable pathological response to preoperative chemoradiotherapy in locally advanced rectal cancer
por: Yu, Jing, et al.
Publicado: (2016)

MiR‐320b/RAD21 axis affects hepatocellular carcinoma radiosensitivity to ionizing radiation treatment through DNA damage repair signaling
por: Wang, Jianyang, et al.
Publicado: (2020)

Depression in breast cancer patients who have undergone mastectomy: A national cohort study
por: Kim, Min-Su, et al.
Publicado: (2017)

Risk factors of locoregional relapse in locally advanced breast cancer treated with neoadjuvant chemotherapy following mastectomy and radiotherapy
por: Huang, Liang, et al.
Publicado: (2016)

Sequencing chemotherapy and radiotherapy in locoregional advanced breast cancer patients after mastectomy – a retrospective analysis
por: Piroth, Marc D, et al.
Publicado: (2008)

Associations of Genetic Variations in Mismatch Repair Genes MSH3 and PMS1 with Acute Adverse Events and Survival in Patients with Rectal Cancer Receiving Postoperative Chemoradiotherapy
por: Yang, Jie, et al.
Publicado: (2019)

Genetic polymorphisms in genes regulating cell death and prognosis of patients with rectal cancer receiving postoperative chemoradiotherapy
por: Chen, Hongxia, et al.
Publicado: (2023)

Impact of clinical-pathological factors on locoregional recurrence in mastectomy patients with T1-2N1 breast cancer: who can omit adjuvant radiotherapy?
por: Wang, Xiaofang, et al.
Publicado: (2021)

An Eighteen-Gene Classifier Predicts Locoregional Recurrence in Post-Mastectomy Breast Cancer Patients
por: Cheng, Skye H., et al.
Publicado: (2016)

Postmastectomy radiotherapy reduces locoregional and disease recurrence in patients with stage II–III triple-negative breast cancer treated with neoadjuvant chemotherapy and mastectomy
por: Chen, Xingxing, et al.
Publicado: (2018)

Prognostic value of plasma Epstein–Barr virus DNA level during posttreatment follow-up in the patients with nasopharyngeal carcinoma having undergone intensity-modulated radiotherapy
por: Li, Wen-Fei, et al.
Publicado: (2017)

Treatment results of breast cancer patients with locoregional recurrence after mastectomy
por: Jeong, Yuri, et al.
Publicado: (2013)

Prognostic Factors for Distant Metastasis in Patients with Locoregional Recurrence after Mastectomy
por: Jeong, Yuri, et al.
Publicado: (2015)

Implications of constructed biologic subtype and its relationship to locoregional recurrence following mastectomy
por: Dominici, Laura S, et al.
Publicado: (2012)

Changes in pulmonary function tests in breast carcinoma patients treated with locoregional post-mastectomy radiotherapy: results of a pilot study
por: AlSaeed, Eyad Fawzi, et al.
Publicado: (2017)

Non-coplanar Volumetric Modulated Arc Therapy for Locoregional Radiotherapy of Left-sided Breast Cancer Including Internal Mammary Nodes
por: Xu, Yuan, et al.
Publicado: (2021)

Comprehensive prognostic modeling of locoregional recurrence after radiotherapy for patients with locoregionally advanced hypopharyngeal squamous cell carcinoma
por: Liu, Hongjia, et al.
Publicado: (2023)

Clinical outcomes of carbon‐ion radiotherapy for patients with locoregionally recurrent nasopharyngeal carcinoma
por: Hu, Jiyi, et al.
Publicado: (2020)

Establishment of a risk scoring system for predicting locoregional recurrence in T1 to T2 node-negative breast cancer patients treated with mastectomy: Implications for postoperative radiotherapy
por: Li, Jin-luan, et al.
Publicado: (2017)

Effectiveness and cost-effectiveness analysis of nimotuzumab for the radiotherapy of locoregionally advanced nasopharyngeal carcinoma
por: Fei, Zhaodong, et al.
Publicado: (2020)

Induction chemotherapy followed by radiotherapy versus concurrent chemoradiotherapy in the treatment of different risk locoregionally advanced nasopharyngeal carcinoma
por: Liu, Li-Ting, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_8c13eo6l6rls3thc7ukadqebi4